BeiGene, Ltd. 13D and 13G filings for Leap Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-09-28 6:58 pm Purchase |
2021-09-24 | 13D | Leap Therapeutics, Inc. LPTX |
BeiGene Ltd. BGNE |
1,215,307 13.200% |
254,380 (+26.47%) |
Filing |